Publications by authors named "Ching H Chang"

Claim this Profile
C
Clinical effectiveness of decoction form of herbal medicine in primary care treatment of allergic rhinitis: A retrospective cohort study.
Mi Ju Son, Sungha Kim, Young-Eun Kim, Bo-Young Kim, Chang-Sub Yeum, Ching Hao Chang

Integr Med Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fine and hyperfine coupling constants of the -β-cyanovinyl radical, HCCHCN.
Masakazu Nakajima, Yi-Ting Liu, Ching Hua Chang, Kenji Seiki, Yoshihiro Sumiyoshi

Phys Chem Chem Phys· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Man with blurry vision following fever.
Ching Hsiung Chang, Chi-Tung Peng, Chi-Wei Chen

Emerg Med J· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.
Alison M Strack, Ester Carballo-Jane, Sheng-Ping Wang, Jiyan Xue, Xiaoli Ping, Ching H Chang

J Lipid Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzimidazolones: a new class of selective peroxisome proliferator-activated receptor γ (PPARγ) modulators.
Weiguo Liu, Fiona Lau, Kun Liu, Harold B Wood, Gaochao Zhou, Ching H Chang

J Med Chem· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose.
Ester Carballo-Jane, Zhu Chen, Edward O'Neill, Jun Wang, Charlotte Burton, Ching H Chang

Bioorg Med Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic acid (MK-0533): a novel selective peroxisome proliferator-activated receptor gamma modulator for the treatment of type 2 diabetes mellitus with a reduced potential to increase plasma and extracellular fluid volume.
John J Acton, Taro E Akiyama, Ching H Chang, Lawrence Colwell, Sheryl Debenham

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a peroxisome proliferator activated receptor gamma (PPARgamma) modulator with balanced PPARalpha activity for the treatment of type 2 diabetes and dyslipidemia.
Weiguo Liu, Kun Liu, Harold B Wood, Margaret E McCann, Thomas W Doebber, Ching H Chang

J Med Chem· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration.
Xun Chen, Charlotte Burton, Xuelei Song, Lesley McNamara, Annunziata Langella, Ching H Chang

Int J Biol Sci· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Ching H Chang, Lesley A McNamara, Margaret S Wu, Eric S Muise, Yejun Tan

Eur J Pharmacol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis